drugset / Trial / NCT04222855
Efficacy of Diltiazem for the Control of Blood Pressure in Puerperal Patients With Severe Preeclampsia
Completed
42 enrolled
Hospital de la Mujer
Calzada-Mendoza, Claudia, PhD · collabOcharan-Hernández, Esther, MD, PhD · collabVargas-De-León, Cruz, MSc · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Both preeclampsia and eclampsia are important health problems, being an important cause of maternal death in the world. Nifedipine has been used as the drug of choice for the treatment of hypertension during puerperium for more than 25 years. Diltiazem is an alternative calcium antagonist that is 1000 times less potent than nifedipine. There are no reports in the literature, no randomized clinical trials that prove the effectiveness of diltiazem for the control of blood pressure in post-partum patients with severe preeclampsia.
Timeline
- Start
- 2009-01-01
- Primary completion
- 2009-05-30
- Completion
- 2009-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diltiazem | Small molecule | 60 mg | Oral |